Collectively, lncRNA AGAP2-AS1 silencing inhibited the expression of PDLIM5, and weakened the proliferation, migration and invasion of prostate cancer cells via miR-195-5p up-regulation in vitro. Here, AGAP2 is linked to prostate carcinoma.